InvestorsHub Logo
Followers 13
Posts 1320
Boards Moderated 0
Alias Born 12/30/2016

Re: None

Friday, 09/15/2017 9:33:48 PM

Friday, September 15, 2017 9:33:48 PM

Post# of 7747
The game is Afoot!!!!

Confidential Treatment Order filed 09/15/2017.

I wonder what that might contain, one month before the special meeting............?


CytRx Corporation
File No. 0-15327 - CF#35342
_____________________
CytRx Corporation submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 8-K filed on August 1, 2017.
Based on representations by CytRx Corporation that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit will not be released to the public for the time period specified:
Exhibit 10.1 through July 27, 2027
For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Brent J. Fields
Secretary



Edgar


Whatever it is it has to do with the 8k dealing with the DISCLOSURE OF MATERIAL DEFINITIVE AGREEMENTS WITH NANTCELL, INC and remains confidential for 10 Years!